High Mark Wealth Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 19,995 shares of CRNX stock, worth $1.12 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
19,995
Previous 19,995
-0.0%
Holding current value
$1.12 Million
Previous $895,000
14.08%
% of portfolio
0.56%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding CRNX
# of Institutions
241Shares Held
79.6MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$349 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$330 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$277 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$250 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $3.01B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...